Takeda and Biological E team up for dengue vaccine | Top Vip News
[ad_1] Takeda, a global biopharmaceutical company, and Biological E. Limited (BE) on Tuesday announced a strategic partnership to accelerate access to Qdenga (quadrivalent dengue vaccine). [Live, Attenuated]) (TAK-003), multi-dose vials (MDV). A press release from Takeda said these doses will eventually be available for purchase by governments of endemic countries no later than 2030 to … Read more